Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.-论文-万方医学网

第一作者： Andrew S,Chi

第一单位： NYU Langone Health and School of Medicine, New York, NY, USA.

作者： Andrew S,Chi ^[1] ; Rohinton S,Tarapore ^[2] ; Matthew D,Hall ^[3] ; Nicole,Shonka ^[4] ; Sharon,Gardner ^[1] ; Yoshie,Umemura ^[5] ; Ashley,Sumrall ^[6] ; Ziad,Khatib ^[7] ; Sabine,Mueller ^[8] ; Cassie,Kline ^[8] ; Wafik,Zaky ^[9] ; Soumen,Khatua ^[9] ; Shiao-Pei,Weathers ^[9] ; Yazmin,Odia ^[10] ; Toba N,Niazi ^[7] ; Doured,Daghistani ^[7] ; Irene,Cherrick ^[11] ; David,Korones ^[12] ; Matthias A,Karajannis ^[13] ; Xiao-Tang,Kong ^[14] ; Jane,Minturn ^[15] ; Angela,Waanders ^[15] ; Isabel,Arillaga-Romany ^[16] ; Tracy,Batchelor ^[16] ; Patrick Y,Wen ^[17] ; Krystal,Merdinger ^[2] ; Lee,Schalop ^[2] ; Martin,Stogniew ^[2] ; Joshua E,Allen ^[2] ; Wolfgang,Oster ^[2] ; Minesh P,Mehta ^[18]

作者单位： NYU Langone Health and School of Medicine, New York, NY, USA. ^[1] Oncoceutics, Philadelphia, PA, USA. ^[2] Radiation Oncology, Miami Cancer Institute, 8900 N. Kendall Drive, Miami, FL, 33176, USA.;Nicklaus Children's Hospital, Miami, FL, USA. ^[3] University of Nebraska Medical Center, Omaha, NE, USA. ^[4] University of Michigan, Ann Arbor, MI, USA. ^[5] Levine Cancer Institute, Charlotte, NC, USA. ^[6] Nicklaus Children's Hospital, Miami, FL, USA. ^[7] University of California, San Francisco, San Francisco, CA, USA. ^[8] M.D. Anderson Cancer Center, Houston, TX, USA. ^[9] Radiation Oncology, Miami Cancer Institute, 8900 N. Kendall Drive, Miami, FL, 33176, USA. ^[10] SUNY Upstate Medical University, Syracuse, NY, USA. ^[11] University of Rochester, Rochester, NY, USA. ^[12] Memorial Sloan Kettering Cancer Center, New York City, NY, USA. ^[13] University of California, Irvine, CA, USA. ^[14] Childrens Hospital of Philadelphia, Philadelphia, PA, USA. ^[15] Massachusetts General Hospital, Boston, MA, USA. ^[16] Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. ^[17] Oncoceutics, Philadelphia, PA, USA. MineshM@baptisthealth.net.;Radiation Oncology, Miami Cancer Institute, 8900 N. Kendall Drive, Miami, FL, 33176, USA. MineshM@baptisthealth.net. ^[18]

医学主题词青少年(Adolescent);成年人(Adult);抗肿瘤药(Antineoplastic Agents);脑肿瘤(Brain Neoplasms);儿童(Child);儿童, 学龄前(Child, Preschool);女(雌)性(Female);随访研究(Follow-Up Studies);神经胶质瘤(Glioma);组蛋白类(Histones);人类(Humans);咪唑类(Imidazoles);男(雄)性(Male);突变(Mutation);预后(Prognosis);吡啶类(Pyridines);嘧啶类(Pyrimidines);受体, 多巴胺D2(Receptors, Dopamine D2);存活率(Survival Rate);青年人(Young Adult)

DOI 10.1007/s11060-019-03271-3

PMID 31456142

发布时间 2021-11-14

检索历史清除

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.

Journal of neuro-oncology

相似文献

同项目论文

Journal of neuro-oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.

Journal of neuro-oncology

相似文献

同项目论文

Journal of neuro-oncology

相关期刊

检索历史清除